Lawsuit claims Novo Nordisk delayed generic Victoza using patent tactics and settlements, preserving monopoly pricing and ...

Novo Nordisk faces a class action lawsuit for allegedly monopolizing its diabetes drug Victoza through patent misuse and ...

A class action lawsuit was filed in New York federal court on Friday accusing Novo Nordisk (NVO) of running a "pay-for-delay" ...

Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the ...

For millions of people with migraine, finding effective relief can be a frustrating journey marked by trial and error with various therapies. Hope may be on the ...

Lawsuit alleges a 2019 settlement delayed Teva's generic Victoza launch, with plaintiffs seeking unspecified monetary damages ...

Company Further Examining the Pursuit of the World's First Oral Liraglutide Product ...

Novo Nordisk will pay nearly $58.7 million to settle a civil lawsuit claiming the company’s sales team failed to share accurate information about health risks associated with the diabetes drug Victoza ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new research suggests they may also reduce the risk of early death in colon cancer ...

Beyond diabetes control and weight management, GLP-1s could have yet another benefit: helping with migraines. In a small study, a GLP-1 drug shrank the number of days people spent with a migraine by ...